Safety of Surgery after Neoadjuvant Targeted Therapies in Non-Small Cell Lung Cancer: A Narrative Review

New drugs, including immune checkpoint inhibitors and targeted therapy, have changed the prognosis in a subset of patients with advanced lung cancer, and are now actively investigated in a number of trials with neoadjuvant and adjuvant regimens. However, no phase III randomized studies were publishe...

Descripción completa

Detalles Bibliográficos
Autores principales: Marjanski, Tomasz, Dziedzic, Robert, Kowalczyk, Anna, Rzyman, Witold
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8622767/
https://www.ncbi.nlm.nih.gov/pubmed/34830123
http://dx.doi.org/10.3390/ijms222212244

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8622767/
https://www.ncbi.nlm.nih.gov/pubmed/34830123
http://dx.doi.org/10.3390/ijms222212244

Ejemplares similares